These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6774434)

  • 1. Identification of D dimer-E complex in disseminated intravascular coagulation.
    Whitaker AN; Rowe EA; Masci PP; Gaffney PJ
    Thromb Res; 1980 May 1-15; 18(3-4):453-9. PubMed ID: 6774434
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
    Lane DA; Preston FE; VanRoss ME; Kakkar VV
    Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of fibrinogen derivatives in plasma samples.
    Graeff H; von Hugo R
    Thromb Diath Haemorrh; 1972 Jul; 27(3):610-8. PubMed ID: 4197047
    [No Abstract]   [Full Text] [Related]  

  • 4. The occurrence and clinical relevance of fibrin fragments in blood.
    Gaffney PJ
    Ann N Y Acad Sci; 1983 Jun; 408():407-23. PubMed ID: 6575697
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of fibrinogen degradation product in severe liver disorders by immunoblotting.
    Tanaka M; Ohkita T
    Tohoku J Exp Med; 1987 Nov; 153(3):179-87. PubMed ID: 3433274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin lysis of fibrinogen and fibrin and the antigenic properties of their degradation products.
    Ekert H; Muntz RH
    Br J Haematol; 1972 Jan; 22(1):103-10. PubMed ID: 4258329
    [No Abstract]   [Full Text] [Related]  

  • 9. Rocket immunoelectrophoresis for the rapid quantitation of plasma fibrinogen.
    Saoji AM; Jad CY; Kelkar SS
    Indian J Pathol Microbiol; 1984 Jan; 27(1):1-5. PubMed ID: 6511021
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
    Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
    Horan JT; Francis CW
    Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin, thrombin and prothrombin fragments in plasma of normal individuals and of patients with laboratory evidence of disseminated intravascular coagulation.
    McDuffie FC; Giffin C; Niedringhaus R; Mann KG; Owen CA; Bowie EJ; Peterson J; Clark G; Hunder GG
    Thromb Res; 1979; 16(5-6):759-73. PubMed ID: 118542
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
    Greenberg CS; Devine DV; McCrae KM
    Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin degradation product (FnDP) assays: analysis of standardization issues and target antigens in plasma.
    Gaffney PJ; Edgell T; Creighton-Kempsford LJ; Wheeler S; Tarelli E
    Br J Haematol; 1995 May; 90(1):187-94. PubMed ID: 7786784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of heparin on fibrinogen formation during experimental toxic syndrome of disseminated intravascular coagulation].
    Barkagan ZS; Momot AP; Glazunova GA; Taranina TS; Koltakova SI
    Ukr Biokhim Zh (1978); 1988; 60(1):23-9. PubMed ID: 3363673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.
    Whitaker AN; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ; Bunce IH
    J Clin Pathol; 1984 Aug; 37(8):882-7. PubMed ID: 6206097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
    Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ristocetin precipitation test: a new simple test for detection of fibrin monomer and fibrin degradation products.
    Watanabe K; Tullis JL
    Am J Clin Pathol; 1978 Oct; 70(4):691-6. PubMed ID: 707435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin D-dimer in thrombogenic disorders.
    Matsuo T; Kobayashi H; Kario K; Suzuki S
    Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-Dimer Testing: Laboratory Aspects and Current Issues.
    Thachil J; Lippi G; Favaloro EJ
    Methods Mol Biol; 2017; 1646():91-104. PubMed ID: 28804821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.